OMI — Owens & Minor, Inc.

Owens & Minor (OMI) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: $697 million, up from $687 million year-over-year. Adjusted for a one-time $6 million revenue benefit in Q3 2024, this reflects a growth rate of approximately 3.4%.
• Adjusted EBITDA: $92 million, down from $108 million in Q3 2024, impacted by the previous year's one-time benefit and rising product costs.
• Adjusted Net Income: $0.25 per share, compared to $0.36 per share in Q3 2024. Year-to-date adjusted net income per share was $0.80, up from $0.64 in 2024.
• Debt: Net debt stood at $2.1 billion, with expectations for only slight reductions by year-end due to costs associated with exiting a previous acquisition and inventory challenges.

2. Strategic Updates and Business Highlights

• Divestiture Announcement: OMI announced a definitive agreement to sell its Products & Healthcare Services (P&HS) segment to Platinum Equity, allowing the company to focus solely on its Patient Direct business.
• Market Positioning: The company aims to enhance its role in home-based care, leveraging its existing infrastructure and expanding payer relationships, particularly in diabetes and sleep apnea care.
• Technology Investments: OMI plans to invest in technology and automation to improve patient experience and operational efficiency.
• Preferred Provider Agreements: A new agreement with Optum is expected to drive future growth, with a focus on expanding market reach.

3. Forward Guidance and Outlook

• 2025 Guidance: OMI reaffirmed its full-year revenue guidance of $2.76 billion to $2.82 billion, adjusted net income of $1.02 to $1.07 per share, and adjusted EBITDA of $376 million to $382 million.
• Q4 Expectations: Revenue is expected to show seasonal improvement compared to Q3, but overall growth may trend towards the lower end of the guidance range due to previous one-time benefits.

4. Bad News, Challenges, or Points of Concern

• Customer Loss: A significant customer loss in 2026 is anticipated, which could impact revenue and profitability, although the lost contract was noted as not being margin-attractive.
• Stranded Costs: Ongoing stranded costs from the divestiture are expected to be around $40 million annually, which could weigh on financial performance.
• Inventory Imbalance: Challenges related to a new kitting facility have led to temporary inventory issues, affecting cash flow and operational efficiency.

5. Notable Q&A Insights

• Durability of Trends: Management expressed confidence in sustaining growth trends into 2026, despite the anticipated loss of a major customer.
• Impact of Optum Agreement: The early-stage Optum agreement is expected to create significant opportunities, with a strong sales force working to penetrate the network.
• Cash Flow Clarifications: The company clarified that free cash flow was impacted by discontinued operations, but continuing operations generated positive cash flow, with expectations for improvement in 2026 as costs associated with the lost contract decrease.

Overall, Owens & Minor is transitioning towards a focused strategy in home-based care, with a positive outlook despite some challenges and expected customer losses.